3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
2
Withdrawn
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Leukemia, Myeloid, Acute
15
Leukemia, Lymphocytic, Chronic, B-Cell
11
Burkitt Lymphoma
10
Lymphoma
9
Leukemia
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, Follicular
8
Lymphoma, Non-Hodgkin
7
Lymphoma, Mantle-Cell
7
Lymphoma, B-Cell, Marginal Zone
7
Myelodysplastic Syndromes
6
Multiple Myeloma
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Myeloproliferative Disorders
5
Lymphoma, Large B-Cell, Diffuse
5
Hodgkin Disease
5
Lymphoma, Large-Cell, Immunoblastic
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Accelerated Phase
4
Hematologic Neoplasms
4
Congenital Abnormalities
4
Sezary Syndrome
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Cutaneous
3
Leukemia, Biphenotypic, Acute
3
Waldenstrom Macroglobulinemia
2
Recurrence
2
Primary Myelofibrosis
2
Neoplasms, Plasma Cell
2
Interventions
selinexor
1
liposomal doxorubicin
1
ixazomib
1
fludarabine phosphate
1
Temozolomide
1
PM 01183
1
Melphalan
1
Irinotecan
1
Erlotinib Hydrochloride
1
Electroacupuncture
1
Busulfan
1
Biopsy, Fine-Needle
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Sarcoma, Ewing
×
fludarabine phosphate
×
Clear all
NCT01969942
2017-05-09
ASCT
University of Louisville
Phase 1
Withdrawn